Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

-  Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027

-  Equity settlement mechanisms also agreed for milestone payments and contingent acquisition consideration